Silver Book Fact

Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.

Dellapina E, Ory- Magne F, Regragui W, Thalamas C, et al. Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease. Pain. 2012; 153(11): 2267-73. https://journals.lww.com/pain/Abstract/2012/11000/Effect_of_subthalamic_deep_brain_stimulation_on.18.aspx

Reference

Title
Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease
Publication
Pain
Publication Date
2012
Authors
Dellapina E, Ory- Magne F, Regragui W, Thalamas C, et al.
Volume & Issue
Volume 153, Issue 11
Pages
2267-73
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • Researchers have discovered that some types of glial cells have a major impact on persistent neuropathic pain and that targeting these cells may result in a new class of disease…  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • A biopsychosocial approach (i.e., one that takes into account physical, emotional, and environmental factors in the assessment and treatment of pain) has been found to improve the pain care of…  
  • Antiepileptic drugs relieve persistent neuropathic pain. One meta-analysis found gabapentin to be associated with moderate benefit (equivalent to 30% pain relief) in close to 1 in 2 patients, and…